Background Chronic kidney disease (CKD) is a risk factor for embolic stroke, and many
nonvalvular atrial fibrillation (NVAF) patients have concomitant CKD. Anticoagulation …

Background In patients with end stage renal disease and atrial fibrillation (AF), undergoing
chronic dialysis, direct oral agents are contraindicated and warfarin does not fully prevent …

Anticoagulation to reduce thromboembolic stroke risk due to nonvalvular atrial fibrillation in
ESKD is associated with increased bleeding. There is an existing debate in ESKD centers …

Background The prevalence of atrial fibrillation (AF) in end stage kidney disease (ESKD)
patients undergoing dialysis is high, however, the high risk of bleeding often hampers with a …

Prophylactic left atrial appendage occlusion has been suggested as a means of reducing
cardioembolism risk in patients with atrial fibrillation. Its clinical benefits have been …

Abstract Introduction and Objectives Advanced chronic kidney disease (A‐CKD) combined
with atrial fibrillation increases the risk of both thrombogenic and bleeding events. Left atrial …

Background Chronic kidney disease (CKD) and end‐stage renal disease are considered
independent risk factors for developing atrial fibrillation (AF). Percutaneous occlusion of left …

Atrial fibrillation (AF) is the most common arrhythmia in chronic kidney disease (CKD), with a
close bidirectional relationship between the two entities. The presence of CKD in AF …

Background Percutaneous left atrial appendage closure (LAAC) has been proposed as an
alternative to anticoagulation therapy in patients with nonvalvular atrial fibrillation (NVAF) to …

Objective In patients with atrial fibrillation (AF) and end-stage renal disease (ESRD), oral
anticoagulants are contraindicated, and left atrial appendage occlusion (LAAO) is an …